Search

Your search keyword '"Villarroya, A."' showing total 6,184 results

Search Constraints

Start Over You searched for: Author "Villarroya, A." Remove constraint Author: "Villarroya, A."
6,184 results on '"Villarroya, A."'

Search Results

3. Sparse Domination of Singular Bilinear Forms on Non-Homogeneous spaces

4. Effect of rhGH treatment on lipidome and brown fat activity in prepuberal small for gestational age children: a pilot study

5. SIRT1 regulates hepatic vldlr levels

6. Zigzag tenotomy of the extensor hallucis longus through minimally invasive surgery in cadaveric specimens: description of a new technique

9. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

11. Aprendizaje del esquí alpino: eficacia de la metodología observacional por pares y la nueva herramienta ASLOT-2

15. PP2A-B55 phosphatase counteracts Ki-67-dependent chromosome individualization during mitosis

16. Experiences for Geriatric Care from Nursing Students’ Knowledge: A Qualitative Approach

20. New Local T1 Theorems on non-homogeneous spaces

21. Adipose tissue plasticity in pheochromocytoma patients suggests a role of the splicing machinery in human adipose browning

22. Social Perception of Zoos and Aquariums: What We Know and How We Know It

27. Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments

33. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial

40. Vivencias de las personas mayores de una residencia durante el confinamiento por la COVID-19: un estudio cualitativo

42. A Hybrid Methodology for the Evaluation of Clinical Practice in Final-Year Nursing Students

44. Wild bee larval food composition in five European cities

45. Vaccination status and outcomes in critical COVID-19 patients

46. Analytical Model of Memory-Bound Applications Compiled with High Level Synthesis

47. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

49. Sparse domination results for compactness on weighted spaces

50. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy

Catalog

Books, media, physical & digital resources